John J Sramek
Overview
Explore the profile of John J Sramek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sramek J, Murphy M, Adcock S, Stark J, Cutler N
Rev Recent Clin Trials
. 2021 Feb;
16(3):232-241.
PMID: 33563172
Background: Phase 1 studies comprise the first exposure of a promising new chemical entity in healthy volunteers or, when appropriate, in patients. To assure a solid foundation for subsequent drug...
2.
Sramek J, Murphy M, Cutler N
Dialogues Clin Neurosci
. 2017 Feb;
18(4):447-457.
PMID: 28179816
Although a number of studies have observed that females respond better to serotonergic antidepressants than males and that postmenopausal females have a diminished response to antidepressants compared with younger females,...
3.
Sramek J, Hardy L, Bieck P, Zamora C, Versavel M, Kharidia J, et al.
CNS Neurosci Ther
. 2016 Feb;
22(5):404-12.
PMID: 26849844
Introduction: SEP-432 is a triple monoamine reuptake inhibitor of norepinephrine (NE), serotonin (5-HT), and dopamine (DA), based on in vitro binding studies. We sought evidence that SEP-432 engages these monoamine...
4.
Sramek J, Cutler N
Curr Top Behav Neurosci
. 2011 Mar;
8:231-49.
PMID: 21374019
There is a large body of literature debating whether and how gender affects the metabolism, side-effect profile, and efficacy of antidepressants. Gender differences in antidepressant pharmacokinetics and efficacy profiles have...
5.
Sramek J, Cutler N, Shiovitz T
J Clin Psychopharmacol
. 2003 Nov;
23(6):679-80.
PMID: 14624207
No abstract available.
6.
Zarotsky V, Sramek J, Cutler N
Am J Health Syst Pharm
. 2003 Mar;
60(5):446-52.
PMID: 12635450
The pharmacology, dosage, adverse effects, efficacy, and economics of galantamine hydrobromide are discussed. Galantamine hydrobromide is a tertiary alkaloid that has been extracted from plant sources and is now synthesized...
7.
Frackiewicz E, Herrera J, Sramek J, Collazo Y, Lawson W
Psychiatry
. 2003 Jan;
65(4):371-4.
PMID: 12530340
A growing body of scientific evidence over the last two decades suggests that certain ethnic groups may require lower dosages of standard antipsychotics for the treatment of schizophrenia symptoms. Recent...
8.
Sramek J, Zarotsky V, Cutler N
Drugs
. 2002 Jul;
62(11):1635-48.
PMID: 12109925
In recent years generalised anxiety disorder (GAD) has become a much better defined disorder, with specific criteria distinguishing it from the other anxiety disorders; however, it still lacks the same...